Immunoregulatory T cell epitope peptides for the treatment of allergic disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Immunoregulatory T cell epitope peptides for the treatment of allergic disease.
- Published In:
- Immunotherapy, 13(15), 1283-1291 (2021)
- Authors:
- Ramchandani, Rashi, Hossenbaccus, Lubnaa, Ellis, Anne K
- Database ID:
- RPEP-05706
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05706APA
Ramchandani, Rashi; Hossenbaccus, Lubnaa; Ellis, Anne K. (2021). Immunoregulatory T cell epitope peptides for the treatment of allergic disease.. Immunotherapy, 13(15), 1283-1291. https://doi.org/10.2217/imt-2021-0133
MLA
Ramchandani, Rashi, et al. "Immunoregulatory T cell epitope peptides for the treatment of allergic disease.." Immunotherapy, 2021. https://doi.org/10.2217/imt-2021-0133
RethinkPeptides
RethinkPeptides Research Database. "Immunoregulatory T cell epitope peptides for the treatment o..." RPEP-05706. Retrieved from https://rethinkpeptides.com/research/ramchandani-2021-immunoregulatory-t-cell-epitope
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.